Clinical trial reportNature medicinePublished
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, University of Pennsylvania, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Nature medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Adenoviridae; Carcinoma in Situ; BCG Vaccine; Combined Modality Therapy; Aged; Aged, 80 and over; Middle Aged; Female; Male; Oncolytic Virotherapy; Oncolytic Viruses
- PubMed ID
- 38844794
- Added to directory
- Source checked